Doç. Dr. MURAT TÜRK

Makaleler 97

1. Identifying Future Risk Factors of Uncontrolled Asthma Control: The TAAR Study Perspective.

Bozkurt N., Abadoglu O., Ozturk Onaran A. B., Gokmen D., Koycu Buhari G., Aydin O., et al.

The Journal of asthma : official journal of the Association for the Care of Asthma , ss.1-17, 2025 (SCI-Expanded, Scopus)

2. Molecular IgE Reactivity Profiling With Micro-Arrayed Allergens Reveals Distinct Interregional Patterns of Sensitization and a Hypoallergenic Region in Türkiye.

Kazancioglu A., Huang H., Aksakal S., Bulut I., Buzan M., Chen K., et al.

Allergy , 2025 (SCI-Expanded, Scopus)

3. Benralizumab in severe eosinophilic asthma: A real-life data from Türkiye

ÇELEBİ SÖZENER Z., Özdel Öztürk B., Şahinoğlu E., KÖYLÜCE S., TÜRK M., AYDIN Ö., et al.

Respiratory Medicine , cilt.248, 2025 (SCI-Expanded, Scopus)

4. Key Predictors of Adherence to a Mobile Health App for Managing Chronic Spontaneous Urticaria.

Viegas H., Sousa-Pinto B., Vieira R. J., Ramanauskaite A., Witte-Händel E., Gimenez-Arnau A., et al.

Clinical and translational allergy , cilt.15, sa.11, 2025 (SCI-Expanded, Scopus)

5. Asthma Control Test: Is a Physician Referral Necessary?

Aktas Yapici E., TÜRK M., Bozkurt Yilmaz H. E., Seker S., KÖYLÜCE S., AÇAR E., et al.

ASTHMA ALLERGY IMMUNOLOGY , 2025 (ESCI)

6. Efficacy of Omalizumab, Dupilumab, and Remibrutinib in Chronic Spontaneous Urticaria: Phase Data and Placebo Response.

Türk M., Yılmaz İ., Ertaş R., Kocatürk E.

Allergy , 2025 (SCI-Expanded, Scopus)

7. Management of Chronic Spontaneous Urticaria Made Practical: What Every Clinician Should Know

Kocatürk E., Chu D. K., Türk M., Röckmann H., Doorn M. V., Nochaiwong S., et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE , cilt.0, sa.0, 2025 (SCI-Expanded, Scopus)

8. Physical Exercise Improves Symptomatic Dermographism.

Ertaş R., Yücel M. B., Türk M., Ketenci Ertaş Ş., Kocatürk E., Muñoz M.

Clinical and translational allergy , cilt.15, sa.7, 2025 (SCI-Expanded, Scopus)

9. Interval prolongation is an effective and well-tolerated approach when stepping down omalizumab treatment in chronic spontaneous urticaria

KÖYLÜCE S., AÇAR E., ŞEKER S., Yilmaz H. E. B., Yapici E. A., ARSLAN B., et al.

ARCHIVES OF DERMATOLOGICAL RESEARCH , cilt.317, sa.1, 2025 (SCI-Expanded, Scopus)

10. Omalizumab home injection versus hospital administration in severe asthma: Impact on asthma control.

Arslan B., Pacaci Cetin G., Seker S., Bozkurt Yilmaz H. E., Aktas Yapici E., Koyluce S., et al.

Allergy and asthma proceedings , cilt.46, sa.4, ss.274-279, 2025 (SCI-Expanded, Scopus)

11. What Does Radiologic Assessment Contribute to Asthma: A Subanalysis of the Turkish Adult Asthma Registry

KIZILIRMAK D., Uzun O., GÖKMEN D., AYDIN Ö., BAŞYİĞİT İ., DURSUN A. B., et al.

Bratislava Medical Journal , cilt.126, sa.6, ss.1008-1022, 2025 (SCI-Expanded, Scopus)

12. Differences in Expert Opinion on Selection of Initial Biologics and Biologic Switching in Severe Asthma

YILMAZ İ., TÜRK M.

CHEST , sa.5, 2025 (SCI-Expanded, Scopus)

13. Distinct Characteristics of Asthma Overlap Phenotypes: Insights from the Turkish Adult Asthma Registry.

Kepil Ozdemir S., Gemicioglu B., Yildiz F., Hayme S., Alpagat G., Bozkurt N., et al.

The Journal of asthma : official journal of the Association for the Care of Asthma , ss.1-18, 2025 (SCI-Expanded, Scopus)

14. Listening to Urticaria Patients Through Social Media: Analyzing the Impact of the COVID-19 Pandemic

Türk M., Baysal B., Ertaş R., Salman A., Kocatürk Göncü Ö. E.

ASTIM ALLERJI IMMUNOLOJI , cilt.23, sa.1, ss.86-95, 2025 (ESCI)

15. Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE® mobile health study

Sousa-Pinto B., Ramanauskaite A., Neisinger S., Witte-Händel E., Gimenez-Arnau A. M., Guillet C., et al.

Allergy: European Journal of Allergy and Clinical Immunology , cilt.80, sa.3, ss.750-761, 2025 (SCI-Expanded, Scopus)

16. Case Report of Systemic Mastocytosis with Cutaneous Involvement

AÇAR E., TÜRK M., YILMAZ İ.

ASTHMA ALLERGY IMMUNOLOGY , cilt.23, sa.1, ss.100-102, 2025 (ESCI, Scopus) Sürdürülebilir Kalkınma

17. Trends in prescribing montelukast in patients with asthma in real-life: Results from the Turkish adult asthma registry

Beyaz S., Erdinc M., HAYME S., ASLAN A. F., Aydin O., Gokmen D., et al.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA , cilt.53, sa.1, ss.12-25, 2025 (SCI-Expanded, Scopus)

18. Mepolizumab: Which condition benefits more: Nasal polyps or eosinophilic asthma? Mepolizumab: Hangi durum daha fazla fayda sağlar: Burun polipleri mi, eozinofilik astım mı?

AÇAR E., KÖYLÜCE S., ŞEKER S., BOZKURT YILMAZ H. E., AKTAŞ YAPICI E., ARSLAN B., et al.

Tuberkuloz ve Toraks , cilt.73, sa.1, ss.52-59, 2025 (ESCI, Scopus, TRDizin)

19. Factors influencing the prescription of add-on long-acting muscarinic antagonists in real-world asthma management: Insights from a national registry

Gemicioglu B., Gokmen D., Can A., Sevinc C., Oguzulgen I. K., Soyyigit S., et al.

Respiratory Medicine , cilt.236, 2025 (SCI-Expanded, Scopus)

20. Can fluoroquinolones be safely used in patients with immediate hypersensitivity reaction to penicillin?

Acar E., TÜRK M., KÖYLÜCE S., Yilmaz H. E. B., Seker S., Yapici E. A., et al.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA , cilt.53, sa.5, ss.94-99, 2025 (SCI-Expanded, Scopus)

21. Asthma patients with obesity have a unique phenotype: a subanalysis of the Turkish adult asthma registry

ÇELEBİ SÖZENER Z., OĞUZÜLGEN İ. K., Ozalp Ates F. S., Baccioglu A., ARGUN BARIŞ S., EDİGER D., et al.

Journal of Asthma , cilt.62, sa.7, ss.1183-1194, 2025 (SCI-Expanded, Scopus)

22. A New Approach for the Classification of Mechanisms of Chronic Spontaneous Urticaria

YILMAZ İ., TÜRK M.

ASTHMA ALLERGY IMMUNOLOGY , cilt.23, sa.1, ss.1-2, 2025 (ESCI, Scopus) Sürdürülebilir Kalkınma

23. Socioeconomic status has direct impact on asthma control: Turkish adult asthma registry

ARSLAN B., TÜRK M., HAYME S., AYDIN Ö., GÖKMEN D., Buhari G. K., et al.

Clinical and Translational Allergy , cilt.15, sa.1, 2025 (SCI-Expanded, Scopus)

24. GINA step 1-2 therapy: Low-dose ICSformoterol combination taken as needed or moderate-dose ICS-formoterol combination taken as needed?

YILMAZ İ., TÜRK M.

Tüberküloz ve Toraks , cilt.72, sa.4, ss.316-317, 2024 (ESCI, Scopus, TRDizin)

25. Psychological Stress and Urticaria: Pathophysiologic and Therapeutic Updates

Xiang Y., Tuerk M., Ojeda I. C., Elieh-Ali-Komi D., SALMAN A., Kocatuerk E.

CURRENT TREATMENT OPTIONS IN ALLERGY , cilt.11, sa.4, ss.194-210, 2024 (ESCI, Scopus)

26. Turkish Severe Asthma Program (TSAP)

BAVBEK S., soyer ö., DİBEK MISIRLIOĞLU E., BAÇÇIOĞLU A., CAN D., KALPAKLIOĞLU A. F., et al.

ASTIM ALLERJI IMMUNOLOJI , cilt.22, sa.3, ss.339-350, 2024 (ESCI, Scopus)

27. Eating increases disease activity in pediatric patients with symptomatic dermographism

Gungor H. E., TÜRK M., Yucel M. B., Koca S. B., Atamulu K. Y., Maurer M., et al.

Allergy and Asthma Proceedings , cilt.45, sa.6, 2024 (SCI-Expanded, Scopus)

28. The definition of remission in asthma should be unique and specific

Yilmaz I., ÇETİN g., Türk M.

Tüberküloz ve Toraks , cilt.72, sa.2, ss.176-178, 2024 (ESCI, Scopus, TRDizin)

29. The Future Role of Generative AI in Medicine

Turk M., Zeydan E., Arslan S. S., Turk Y.

Journal of clinical practice and research , cilt.46, sa.., ss.211-213, 2024 (TRDizin)

30. Asthma-chronic obstructive pulmonary disease overlap: Results from a national-multicenter study

Çelik G., aydin o., SEN E., demir t., Gemicioglu B., Kıyan E., et al.

Tüberküloz ve Toraks , cilt.72, sa.1, ss.25-36, 2024 (ESCI, Scopus, TRDizin)

31. A global perspective on stepping down chronic spontaneous urticaria treatment: Results of the Urticaria Centers of Reference and Excellence SDown-CSU study

Türk M.

CLINICAL AND TRANSLATIONAL ALLERGY , cilt.14, sa.2, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

32. Patient-Reported Outcomes in Assessing Disease Activity, Control, and Quality of Life in Chronic Spontaneous Urticaria

BEYHAN N., TÜRK M., YILMAZ İ., BAVBEK S.

ASTHMA ALLERGY IMMUNOLOGY , cilt.22, ss.217-224, 2024 (ESCI, Scopus)

33. Revolutionizing Healthcare: The Unprecedented Role of Artificial Intelligence in Medicine

TÜRK M., Zeydan E., Arslan S. S., Turk Y.

ASTHMA ALLERGY IMMUNOLOGY , cilt.22, sa.2, ss.91-93, 2024 (ESCI, Scopus, TRDizin)

34. Characteristics of asthma in an older adult population according to sex and control level: why are asthma symptoms in older women not well-controlled?

KARADOĞAN D., YILMAZEL UÇAR E., YAVUZ Y., BAÇÇIOĞLU A., Oeztuerk A. B., Bozkurt N., et al.

JOURNAL OF ASTHMA , cilt.61, sa.6, ss.539-549, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

35. Capsaicin Pretreatment Increases Mast Cell-Mediated But Not Histamine-Induced Wheal and Erythema Responses: A Proof-of-Concept Study

TÜRK M., YILMAZ İ., Bahcecioglu S. N., PAÇACI ÇETİN G., Elieh-Ali-Komi D., Maurer M.

ASTHMA ALLERGY IMMUNOLOGY , cilt.22, sa.1, ss.49-57, 2024 (ESCI, Scopus, TRDizin)

36. Capsaicin Pretreatment Increases Mast Cell-Mediated But Not Histamine-Induced Wheal and Erythema Responses: A Proof-of-Concept Study

TÜRK M., YILMAZ İ., NAZİK BAHÇECİOĞLU S., PAÇACI ÇETİN G., Elieh-ali-komi D., Maurer M.

ASTHMA ALLERGY IMMUNOLOGY , 2023 (ESCI)

37. Omalizumab in severe asthma with seasonal allergic sensitization

Tuerk M., Tutar N., Yilmaz I.

REVUE FRANCAISE D'ALLERGOLOGIE , cilt.63, sa.5, ss.103675, 2023 (SCI-Expanded, Scopus)

38. FROM THE EDITOR

Turk M.

ASTIM ALLERJI IMMUNOLOJI , cilt.20, sa.3, ss.8-9, 2023 (ESCI, Scopus)

39. Physical activity and dietary habits in patients with asthma: How is it related to asthma control?

AYDIN Ö., Çelebi Sözener Z., MUNGAN V. D., Özbey Ü., BALABAN S., GÖKMEN D., et al.

Obesity Medicine , cilt.38, 2023 (Scopus)

40. Eating Increases and Exercise Decreases Disease Activity in Patients With Symptomatic Dermographism

Ertaş R., Türk M., Yücel M. B., Muñoz M., Ertaş Ş. K., Atasoy M., et al.

Journal of Allergy and Clinical Immunology: In Practice , cilt.11, sa.3, ss.932-940, 2023 (SCI-Expanded, Scopus)

41. In Chronic Spontaneous Urticaria, Complete Response to Antihistamine Treatment Is Linked to Low Disease Activity

Türk M.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , cilt.0, sa.0, ss.1-5, 2023 (SCI-Expanded, Scopus)

42. Picturing asthma in Turkey: results from the Turkish adult asthma registry

Celik G. E., Aydin O., Gokmen D., Buhari G. K., Sozener Z. C., Gemicioglu B., et al.

JOURNAL OF ASTHMA , cilt.60, sa.11, ss.1973-1986, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asthma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide Discontinuing Omalizumab Treatment?

ARSLAN B., PAÇACI ÇETİN G., Turk M., GÜLMEZ İ., YILMAZ İ.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , cilt.183, sa.10, ss.1071-1077, 2022 (SCI-Expanded, Scopus)

44. The External Exposome and Allergies: From the Perspective of the Epithelial Barrier Hypothesis

Sozener Z. C., Yucel U. O., ALTINER S., Ozturk B. O., Cerci P., Turk M., et al.

FRONTIERS IN ALLERGY , cilt.3, 2022 (ESCI)

45. Mast cells, cortistatin, and its receptor, MRGPRX2, are linked to the pathogenesis of chronic prurigo

Kolkhir P., Pyatilova P., Ashry T., Jiao Q., Abad-Perez A. T., Altrichter S., et al.

Journal of Allergy and Clinical Immunology , cilt.149, sa.6, ss.1998, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

46. Epithelial barrier hypothesis: Effect of external exposome on microbiome and epithelial barriers in allergic disease

Sozener Z. C., Ozturk B. O., Cerci P., Turk M., Akin B. G., Akdis M., et al.

ALLERGY , cilt.77, sa.5, ss.1418-1449, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

47. Experience-based advice on stepping up and stepping down the therapeutic management of chronic spontaneous urticaria: Where is the guidance?

Turk M., YILMAZ İ., ŞAHİNER Ü. M., Kocaturk E., ŞEKEREL B. E., Zuberbier T., et al.

ALLERGY , cilt.77, ss.1626-1630, 2022 (SCI-Expanded, Scopus)

48. Food-dependent and food-exacerbated symptomatic dermographism: New variants of symptomatic dermographism

Yücel M. B., Ertas R., Türk M., Muñoz M., Atasoy M., Maurer M.

Journal of Allergy and Clinical Immunology , cilt.149, sa.2, ss.788-790, 2022 (SCI-Expanded, Scopus)

49. Mepolizumab-Related Adverse Events in Severe Eosinophilic Asthma: A Real-Life Study

NAZİK BAHÇECİOĞLU S., TURK M., ATAYIK E., PAÇACI ÇETİN G., ARSLAN B., GÜLMEZ İ., et al.

ASTIM ALLERJI IMMUNOLOJI , cilt.20, sa.2, ss.81-86, 2022 (ESCI, Scopus, TRDizin)

50. Identification of chronic urticaria subtypes using machine learning algorithms

Türk M., Ertaş R., Zeydan E., Türk Y., Atasoy M., Gutsche A., et al.

Allergy: European Journal of Allergy and Clinical Immunology , cilt.77, sa.1, ss.323-326, 2022 (SCI-Expanded, Scopus)

51. The Management of Acute and Chronic Urticaria

YILMAZ İ., PAÇACI ÇETİN G., ARSLAN B., Turk M.

ASTIM ALLERJI IMMUNOLOJI , cilt.20, sa.3, ss.202-204, 2022 (ESCI, Scopus, TRDizin)

52. The adequacy of current diagnostic criteria for making a diagnosis of ABPA

Bahcecioglu S. N., Turk M., PAÇACI ÇETİN G., YILMAZ İ.

TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , cilt.70, sa.2, ss.141-148, 2022 (ESCI, Scopus, TRDizin)

53. Stable and exacerbation period serum cytokine and periostin levels of the five distinct phenotypes of severe asthma

TÜRK M., YILMAZ İ., GÖKAHMETOĞLU S., KOÇ A. N.

Turkish Journal of Medical Sciences , cilt.52, sa.4, ss.1148-1159, 2022 (SCI-Expanded, Scopus, TRDizin)

54. Venom immunotherapy and difficulties encountered before and during immunotherapy: Double sensitization, systemic reactions, treatment with omalizumab, and high dose VIT

PAÇACI ÇETİN G., YILMAZ İ., Turk M., ARSLAN B., Bahcecioglu S. N.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.4, ss.1223-1234, 2022 (SCI-Expanded, Scopus, TRDizin)

55. A case of hypersensitivity developing against trace element solution in total parenteral nutrition, proved by skin prick test

PAÇACI ÇETİN G., Turk M., Bahcecioglu S. N., YILMAZ İ.

EUROPEAN JOURNAL OF CLINICAL NUTRITION , cilt.75, sa.12, ss.1829-1831, 2021 (SCI-Expanded, Scopus)

56. Stable and exacerbation period serum cytokine and periostin levels of the five distinct phenotypes of severe asthma.

Türk M., Yilmaz İ., Gökahmetoğlu S., Koç A. N.

Turkish journal of medical sciences , 2021 (SCI-Expanded, Scopus, TRDizin)

57. Current approach to the diagnosis of allergic bronchopulmonary aspergillosis

Turk M., NAZİK BAHÇECİOĞLU S., YILMAZ İ.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE , cilt.9, sa.6, ss.2546, 2021 (SCI-Expanded, Scopus)

58. High-Dose Omalizumab versus Ligelizumab for the Treatment of Chronic Spontaneous Urticaria: Do Not We Need a Head-To-Head Comparison?

Turk M., YILMAZ İ.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , cilt.182, sa.5, ss.461-462, 2021 (SCI-Expanded, Scopus)

59. Worsening of chronic spontaneous urticaria after intake of hot pepper

TÜRK M., YILMAZ İ., Hawro T., Maurer M.

ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY , cilt.39, sa.1, ss.25-30, 2021 (SCI-Expanded, Scopus)

60. Effectiveness of as-needed antihistamines in chronic spontaneous urticaria patients under omalizumab treatment

TÜRK M., YILMAZ İ., NAZİK BAHÇECİOĞLU S., Can P., Ertas R., KARTAL D., et al.

DERMATOLOGIC THERAPY , cilt.34, sa.1, 2021 (SCI-Expanded, Scopus)

61. Effectiveness of mepolizumab therapy on symptoms, asthma exacerbations, steroid dependence, and small airways in patients with severe eosinophilic asthma

YILMAZ İ., Nazik Bahcecioglu S., Turk M., TUTAR N., PAÇACI ÇETİN G., ARSLAN B.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.4, ss.1953-1959, 2021 (SCI-Expanded, Scopus, TRDizin)

62. The presence of underlying asthma should be investigated in patients diagnosed with ACE inhibitor induced cough

Yilmaz İ., Türk M., Baran K., Çetinkaya Z., Tutar N., Oymak F. S., et al.

Clinical Respiratory Journal , cilt.14, sa.4, ss.382-388, 2020 (SCI-Expanded, Scopus)

63. What Should the Optimal Adrenaline Auto-Injector Needle Length Be?

TÜRK M., Turk G., KOÇ A., KARABIYIK Ö., YILMAZ İ.

ASTIM ALLERJI IMMUNOLOJI , cilt.18, sa.2, ss.82-90, 2020 (ESCI, TRDizin)

64. Efficacy of mepolizumab treatment in oral corticosteroid-dependent severe eosinophilic asthma patients with chronic rhinosinusitis with nasal polyps: single center, real life study

YILMAZ İ., TÜRK M., NAZİK BAHÇECİOĞLU S., TUTAR N., GÜLMEZ İ.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.50, sa.2, ss.433-441, 2020 (SCI-Expanded, Scopus, TRDizin)

65. How to Treat Patients with Chronic Spontaneous Urticaria with Omalizumab: Questions and Answers

TÜRK M., Carneiro-Leao L., Kolkhir P., Bonnekoh H., Buttgereit T., Maurer M.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE , cilt.8, sa.1, ss.113-124, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

66. Does neutrophil-to-lymphocyte ratio have a role among the other prognostic factors of nonsmall cell lung cancer?

YILDIRIM F., SEVİMLİ N., TÜRK M., YILMAZ DEMİRCİ N., YURDAKUL A. S., ÖZTÜRK C.

Eurasian Journal of Pulmonology , cilt.21, sa.3, ss.187, 2019 (ESCI, TRDizin) Sürdürülebilir Kalkınma

67. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias

Yildirim F., TÜRK M., Bitik B., Erbas G., Kokturk N., Haznedaroglu S., et al.

KAOHSIUNG JOURNAL OF MEDICAL SCIENCES , cilt.35, sa.6, ss.365-372, 2019 (SCI-Expanded, Scopus)

68. How to discontinue omalizumab in chronic spontaneous urticaria?

TÜRK M., Maurer M., YILMAZ İ.

ALLERGY , cilt.74, sa.4, ss.821-824, 2019 (SCI-Expanded, Scopus)

69. Urticaria control test might misevaluate disease control in particular patients treated with omalizumab

TÜRK M., YILMAZ İ.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY , cilt.122, sa.3, ss.342-343, 2019 (SCI-Expanded, Scopus)

70. Last station in the eosinophilic asthma with chronic rhinosinusitis and/or nasal polyposis march: Eosinophilic asthma with radiological findings associated with blood eosinophilia

YILMAZ İ., Bahcecioglu S. N., TÜRK M., TUTAR N., OYMAK F. S., GÜLMEZ İ.

JOURNAL OF ASTHMA , cilt.56, sa.2, ss.111-117, 2019 (SCI-Expanded, Scopus)

71. A Rare Case of Multiple Severe Anaphylaxis Caused by Thyme, Black Pepper, Wasp and Honey

TÜRK M., YILMAZ İ.

ASTIM ALLERJI IMMUNOLOJI , cilt.17, sa.2, ss.115-117, 2019 (ESCI, TRDizin)

72. What should the ideal adrenaline auto-injector needle length be?

Turk M., Turk G., Koc A., Karabiyik O., Yilmaz İ.

ASTIM ALLERJI IMMUNOLOJI , cilt.0, sa.0, 2019 (TRDizin)

73. Omalizumab Treatment for Atopic Severe Persistant Asthma: A Single-Center, Long-Term, Real-Life Experience with 38 Patients

TÜRK M., NAZİK BAHÇECİOĞLU S., TUTAR N., OYMAK F. S., GÜLMEZ İ., YILMAZ İ.

Turkish Thoracic Journal , cilt.19, sa.4, ss.187-192, 2018 (Scopus, TRDizin)

74. Two-week intervals during omalizumab treatment may provide better symptom control in selected patients with chronic urticaria

Turk M., Kocaturk E., Cure K., YILMAZ İ.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE , cilt.6, sa.4, ss.1389-1390, 2018 (SCI-Expanded, Scopus)

75. Biologic Targeted Therapies for the Phenotypes of Type-2 High Severe Asthma

YILMAZ İ., Turk M.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE , cilt.6, sa.3, ss.1091-1092, 2018 (SCI-Expanded, Scopus)

76. Combination of omalizumab and bee venom immunotherapy: does it work?

YILMAZ İ., NAZİK BAHÇECİOĞLU S., TÜRK M.

Asia Pacific Allergy , cilt.8, sa.1, ss.2, 2018 (ESCI)

77. The relationship between primary tumor metabolic activity and lymph node and distant organ metastasis in non-small cell lung cancer Küçük Hücreli Dişi Akciǧer Kanserinde Primer Tümör Metabolik Aktivitesi ile Lenf Nodu ve Uzak Organ Metastazi Arasindaki İlişki

Yildirim F., TÜRK M., AKDEMİR Ü. Ö., Yurdakul A. S., ÖZTÜRK C.

Gazi Medical Journal , cilt.29, sa.3, ss.164-168, 2018 (Scopus, TRDizin) Sürdürülebilir Kalkınma

78. Effects of modes, obesity, and body position on non-invasive positive pressure ventilation success in the intensive care unit: A randomized controlled study

Türk M., AYDOĞDU M., GÜRSEL G.

Turkish Thoracic Journal , cilt.19, sa.1, ss.28-35, 2018 (Scopus, TRDizin)

79. Treatment and retreatment with omalizumab in chronic spontaneous urticaria: Real life experience with twenty-five patients

Turk M., YILMAZ İ., Bahcecioglu S. N.

ALLERGOLOGY INTERNATIONAL , cilt.67, sa.1, ss.85-89, 2018 (SCI-Expanded, Scopus)

80. Eosinophilic asthma with nasal polyposis march: Is aspirin-exacerbated respiratory disease the last station?

YILMAZ İ., Turk M., Bahcecioglu S. N.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE , cilt.5, sa.6, ss.1807-1808, 2017 (SCI-Expanded, Scopus)

81. Comment on: "Targeting the PGD(2)/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives"

YILMAZ İ., Turk M.

DRUGS , cilt.77, sa.17, ss.1925-1926, 2017 (SCI-Expanded, Scopus)

82. What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease?

YILMAZ İ., Turk M.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , cilt.196, sa.9, ss.1229-1230, 2017 (SCI-Expanded, Scopus)

83. Successful rapid subcutaneous desensitization to anakinra in a case with a severe immediate-type hypersensitivity reaction

YILMAZ İ., TÜRK M., NAZİK BAHÇECİOĞLU S.

European Annals of Allergy and Clinical Immunology , cilt.50, sa.2, ss.94, 2017 (Scopus)

84. Classification of eosinophilic granulomatosis with polyangiitis phenotypes and treatment based on phenotypes

YILMAZ İ., Turk M., Bahcecioglu S. N.

AUTOIMMUNITY REVIEWS , cilt.16, sa.9, ss.992-993, 2017 (SCI-Expanded, Scopus)

85. Is nonhomogeneous expression of tissue mast cells or allergen specific IgEs bound to tissue mast cells possible?

Turk M., Bahcecioglu S. N., YILMAZ İ.

ASIA PACIFIC ALLERGY , cilt.7, sa.3, ss.179-181, 2017 (ESCI)

86. Comment on: “Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives”

YILMAZ İ., TÜRK M.

Drugs , cilt.77, ss.925-1926, 2017 (SCI-Expanded, Scopus)

87. Ranitidine-Induced Anaphylaxis in a Patient with Acute COPD Exacerbation

YILMAZ İ., TÜRK M.

TURKISH THORACIC JOURNAL , cilt.18, ss.94-95, 2017 (ESCI, Scopus, TRDizin)

88. Impact of pulmonary embolism on acute chronic obstructive pulmonary disease exacerbation

Törk M., Yildirim F., Sevimli N., Köktörk N.

Gazi Medical Journal , cilt.28, sa.3, ss.168-170, 2017 (Scopus, TRDizin)

89. Hospitalization costs of lung cancer diagnosis in Turkey: Is there a difference between histological types and stages?

Türk M.

TUBERKULOZ VE TORAKS , cilt.64, ss.263-268, 2016 (Scopus, TRDizin) Sürdürülebilir Kalkınma

90. Acute Respiratory Distress Syndrome due to Sepsis in Pregnancy

Yıldırım F., Kara İ., TÜRK M., Kat İ.

Journal of Clinical Respiratory Diseases and Care , cilt.2, sa.2, ss.1-3, 2016 (Hakemli Dergi)

91. A Case of Herpes Zoster Associated with Thoracic Trauma

TÜRK M., Ceylan G. G., Sezen C. B.

RESPİRATORY CASE REPORTS , cilt.5, sa.2, ss.125-127, 2016 (TRDizin)

92. Is Primary Tumor Metabolic Activity a Risk Factor for Occult Lymph Node Metastasis in T1-2N0M0 Non-small Cell Lung Cancer Patients?

Yildirim F., Turk M., Akdemir U. O., Tastepe A. I., Yurdakul A. S.

GAZI MEDICAL JOURNAL , cilt.27, sa.2, ss.71-75, 2016 (ESCI, Scopus, TRDizin)

93. A cost comparison of warfarin vs enoxaparine or new oral anticoagulants used for the treatment of patients with pulmonary embolism

Turk M., Aldag Y., Oguzulgen I. K., Ekim N.

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX , cilt.64, sa.3, ss.198-205, 2016 (ESCI, Scopus, TRDizin)

94. A Case of Langerhans Cell Histiocytosis with Atypical Radiological Presentation

Turk M., Turktas H., Akyurek N.

TURKISH THORACIC JOURNAL , cilt.16, sa.3, ss.154-156, 2015 (ESCI, Scopus)

95. Tracheal Papilloma Treated with Cryotherapy and Interferon-α: A Case Report and Review of the Literature.

YıLDıRıM F., Türk M., DEMIRCAN S., AKYÜREK N., YURDAKUL A.

Case reports in pulmonology , cilt.2015, ss.356796, 2015 (Scopus)

96. Costs of the Patients Hospitalized with Acute Exacerbations of Chronic Obstructive Pulmonary Disease in a University Hospital

Yildirim F., Turk M., Ozturk C.

EURASIAN JOURNAL OF PULMONOLOGY , cilt.17, sa.3, ss.171-175, 2015 (ESCI, TRDizin)

97. The use of plasma and urine neutrophil gelatinase associated lipocalin (NGAL) and Cystatin C in early diagnosis of septic acute kidney injury in critically ill patients

Aydogdu M., Gursel G., Sancak B., Yeni S., Sari G., Tasyurek S., et al.

DISEASE MARKERS , cilt.34, sa.4, ss.237-246, 2013 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 24

1. Kronik Rinosinüzit/Nazal Polipli Geç Başlangıçlı Eozinofilik Astımın T Hücre İmmün Fenotipleri, Periostin ve Fibrinolitik Sistem ile İlişkisi

Taheri S., Yılmaz İ., Eken A., Erdem Ş., Paçacı Çetin G., Arslan B., et al.

29. Ulusal Allerji ve Klinik İmmünoloji Kongresi, Antalya, Türkiye, 29 Kasım - 03 Aralık 2023, (Özet Bildiri)

2. Capsaicin pretreatment increases IgE-mediated but not histamine-induced wheal and erythema responses: a proof of concept study

TÜRK M., YILMAZ İ., NAZİK BAHÇECİOĞLU S., paçacı çetin g., TUTAR N., BARAN KETENCİOĞLU B., et al.

5th GA2LEN Global Urticaria Forum, Berlin, Almanya, 1 - 02 Aralık 2020, (Özet Bildiri)

3. What should the ideal adrenaline auto-injector needle length be?

TÜRK M., Turk G., Koc A., Karabiyik Ö., YILMAZ İ.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portekiz, 1 - 05 Haziran 2019, cilt.74, ss.144-145, (Özet Bildiri)

4. Worsening of chronic spontaneous urticaria after intake of hot pepper

Turk M., YILMAZ İ., Maurer M.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portekiz, 1 - 05 Haziran 2019, cilt.74, ss.612-613, (Özet Bildiri)

5. Astım hastalarında fiziksel aktivite ve beslenme tutum ve davranışların belirlenmesi ve astım kontrolü ile ilişkisinin değerlendirilmesi: ulusal çok merkezli bir araştırma verileri

AYDIN Ö., ÇELEBİ SÖZENER Z., MUNGAN V. D., yıldız F., BARIŞ S., GEMİCİOĞLU B., et al.

Türk Toraks Derneği 22. Ulusal Kongresi, Türkiye, 10 - 14 Nisan 2019, (Özet Bildiri)

6. ASTIM HASTALARINDA FIZIKSEL AKTIVITEVE BESLENME TUTUM VE DAVRANIŞLARINBELIRLENMESI VE ASTIM KONTROLÜ ILEILIŞKISININ DEĞERLENDIRILMESI: ULUSAL ÇOKMERKEZLI BIR ARAŞTIRMA VERILERI

AYDIN Ö., ÇELEBİ SÖZENER Z., MUNGAN V. D., Yıldız F., ARGUN BARIŞ S., GEMİCİOĞLU B., et al.

TÜRK TORAKS DERNEĞİ ULUSLARARASI KATILIMLI 22. YILLIK KONGRESİ, Antalya, Türkiye, 10 - 14 Nisan 2019, ss.90, (Özet Bildiri)

7. Astım hastalarında fiziksel aktivite ve beslenme tutum ve davranışların belirlenmesi ve astım kontrolü ile ilişkisinin değerlendirilmesi: Ulusal çok merkezli bir araştırma verileri

AYDIN Ö., ÇELEBİ SÖZENER Z., MUNGAN V. D., YILDIZ F., ARGUN BARIŞ S., GEMİCİOĞLU B., et al.

Türk Toraks Derneği 22. Yıllık Kongresi, 10 - 14 Nisan 2019, (Tam Metin Bildiri)

8. How to discontinue omalizumab in chronic spontaneous urticaria?

TÜRK M., maurer m., YILMAZ İ.

Global Urticaria Forum, Berlin, Almanya, 5 - 06 Aralık 2018, (Tam Metin Bildiri)

9. Exacebation of chronic spontaneous urticaria after intake of hot pepper

TÜRK M., YILMAZ İ., maurer m.

Global Urticaria Forum, Berlin, Almanya, 5 - 06 Aralık 2018, (Tam Metin Bildiri)

10. Adrenalin otoenjektor iğne uzunluğu erişkin hastalar için yeterli midir?

TÜRK M., türk g., koç a., KARABIYIK Ö., YILMAZ İ.

25 yıllık allerji immünoloji kongresi, Antalya, Türkiye, 17 - 21 Kasım 2018, (Tam Metin Bildiri)

11. Omalizumab tedavi aralığının sonlarına doğru semptom artışı olan hastalarda, ürtiker kontrol testi hastalık kontrolünü yanlış değerlendiriyor olabilir mi?

TÜRK M., YILMAZ İ.

25. ıllık ulusal allerji immünolji kongresi, 17 - 21 Kasım 2018, (Tam Metin Bildiri)

12. Acı biber tüketimi kronik spontan ürtikerli hastalarda semptom kontrolünü bozar mı?

TÜRK M., YILMAZ İ., maurer m.

25. ulusal allerji immünoloji kongresi, Antalya, Türkiye, 17 - 21 Kasım 2018, (Özet Bildiri)

13. Kronik spontan ürtikerde omalizumab tedavisinin sonlandırılması: Gerçek yaşam deneyimi

TÜRK M., maurer m., YILMAZ İ.

25. ulusal allerji immünoloji kongresi, Antalya, Türkiye, 17 - 21 Kasım 2018, (Özet Bildiri)

14. ADRENALİN OTOENJEKTÖR İĞNE UZUNLUĞU ERİŞKİN HASTALAR İÇİN YETERLİ MİDİR?

TÜRK M., TÜRK G., KOÇ A., KARABIYIK Ö., YILMAZ İ.

25. ULUSAL ALERJİ VE KLİNİK İMMÜNOLOJİ KONGRESİ, Türkiye, 17 - 21 Kasım 2018, (Özet Bildiri)

15. Omalizumab treatment in atopic severe persistent asthma: A single center long-term real-life experience with thirty eight patients

TÜRK M., Bahcecioglu N. S., TUTAR N., OYMAK F. S., GÜLMEZ İ., YILMAZ İ.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Munich, Almanya, 26 - 30 Mayıs 2018, ss.672, (Özet Bildiri)

16. Last station in the eosinophilic asthmawith chronic rhinosinusitis and or nasal polyposismarch: Eosinophilic asthma with radiologicalfindings associated with blood eosinophilia

YILMAZ İ., NAZİK BAHÇECİOĞLU S., TÜRK M., TUTAR N., OYMAK F. S., GÜLMEZ İ.

EAACI Annual Congress 2018, Munich, Almanya, 26 - 30 Mayıs 2018, cilt.73, (Özet Bildiri)

17. Omalizumab treatment in atopic severepersistent asthma: A single center long‐termreal‐life experience with thirty eight patients

Türk M., Nazik Bahçecioğlu S., Tutar N., Oymak F. S., Gülmez İ.

EAACI Annual Congress 2018, Munich, Almanya, 26 - 30 Mayıs 2018, cilt.73, (Tam Metin Bildiri)

18. Omalizumab Treatment in Atopic Severe Persistant Asthma: a Single Center Real-Life Experience with Thirty Eight Patients

TÜRK M., NAZİK BAHÇECİOĞLU S., TUTAR N., OYMAK F. S., GÜLMEZ İ., YILMAZ İ.

Türk Toraks Derneği Yıllık Kongresi 2018, 11 - 15 Nisan 2018, cilt.19, (Özet Bildiri)

19. Last Station in the Eosinophilic Asthma with Chronic Rhinosinusitis and/or Nasal Polyposis March: Eosinophilic Asthma with Thorax CT Findings Associated with Blood Eosinophilia

YILMAZ İ., NAZİK BAHÇECİOĞLU S., TÜRK M., TUTAR N., OYMAK F. S., GÜLMEZ İ.

Türk Toraks Derneği Yıllık KOngresi 2018, 11 - 15 Nisan 2018, cilt.19, (Tam Metin Bildiri)

20. Ranitidine-Induced Anaphylaxis in a Patient with Acute COPD Exacerbation

YILMAZ İ., TÜRK M.

Türk Toraks Derneği Yıllık Kongresi 2018, 11 - 15 Nisan 2018, cilt.19, (Özet Bildiri)

21. A patient worsening with acute COPD exacerbation treatment

YILMAZ İ., Turk M.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, Helsinki, Finlandiya, 17 - 21 Haziran 2017, cilt.72, ss.460, (Özet Bildiri)

22. Treatment and retreatment withomalizumab in chronic spontaneous urticaria:real life experience with twenty-five patients

TÜRK M., YILMAZ İ., NAZİK BAHÇECİOĞLU S.

EAACI Congress 2017, 17 - 21 Haziran 2017, (Tam Metin Bildiri)

23. A patient worsening with acute COPDexacerbation treatment

YILMAZ İ., TÜRK M.

EAACI Congress 2017, 17 - 21 Haziran 2017, (Tam Metin Bildiri)

24. BİR EĞİTİM VE ARAŞTIRMA HASTANESİNDE ÇALIŞANLARIN HİZMET KALİTE STANDARTLARI UYGULAMALARIYLA İLGİLİ ALGISI (KAYSERİ EĞİTİM VE ARAŞTIRMA HASTANESİ ÖRNEĞİ)

METİN A., ELİF H., TÜRK M., OĞRAŞ S., ÇİFTÇİ G., ÖKSÜZKAYA A., et al.

IV. ULUSLARARASI SAĞLIKTA PERFORMANS VE KALİTE KONGRESİ, 2 - 04 Mayıs 2013, (Tam Metin Bildiri)

Kitaplar 6

Metrikler

Yayın

129

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

545

H-İndeks (WoS)

Atıf (Scopus)

845

H-İndeks (Scopus)

Atıf (Scholar)

1308

H-İndeks (Scholar)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Proje

Açık Erişim